Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-01 Sale | 2024-02-02 5:03 pm | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 4,267 | $8.1027 | $34,574 | 137,625 (Direct) | View |
| 2023-09-20 Sale | 2023-09-22 4:47 pm | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 37,484 | $6.2877 | $235,688 | 170,916 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-02 5:03 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 112,500 | $0 | 137,625 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-02 5:03 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 4,108 | $8.19 | 137,625 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:47 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 31,250 | $4.47 | 170,916 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:47 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 6,234 | $3.85 | 170,916 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-22 4:47 pm | N/A 2032-08-01 | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 37,484 | $0 | 170,916 (Direct) | View |
Ownership | 2023-06-23 5:01 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Rotman Harris SVP Regulatory Affairs | 0 | $0 | 208,400 (Direct) | View |